natgillin/translations-raw huggingface dataset:
In euglycaemic clamp studies in healthy subjects or in patients with type 1 diabetes, the onset of action of subcutaneous insulin glargine was slower than with human NPH insulin, its effect profile was smooth and peakless, and the duration of its effect was prolonged. 
U ispitivanjima pomoću euglikemijske spone (engl. euglycaemic clamp studies) u zdravih osoba, odnosno u bolesnika sa šećernom bolešću tipa 1, početak djelovanja supkutano primijenjenog inzulina glargina bio je sporiji u odnosu na ljudski NPH inzulin, dok mu je profil učinka bio ravnomjeran, bez vršnih koncentracija, a trajanje produljeno.
A crossover study comparing insulin glargine plus lispro insulin to NPH plus regular human insulin (each treatment administered for 16 weeks in random order) in 26 adolescent type 1 diabetic patients aged 12 to 18 years was also performed. 
Također je provedeno ispitivanje s križnom zamjenom skupina u kojem je uspoređena primjena inzulina glargina i inzulina lispro, u odnosu na primjenu NPH i običnog ljudskog inzulina (svaka terapija primjenjivala se 16 tjedana, nasumičnim redoslijedom), u 26 adolescenata sa šećernom bolešću tipa 1, u dobi od 12 do 18 godina.
Each vial contains 5 ml of solution for injection (equivalent to 500 units) or 10 ml of solution for injection (equivalent to 1000 units). 
Jedna bočica sadrži 5 ml otopine za injekciju (što odgovara 500 jedinica) ili 10 ml otopine za injekciju (što odgovara 1000 jedinica).
To ensure you get the accurate dose, the Lantus cartridges are to be used only with the following pens: - JuniorSTAR which delivers doses in steps of 0.5 units - ClikSTAR, Tactipen, Autopen 24, AllStar or AllStar PRO which deliver doses in steps of 1 unit. 
Kako bi se osigurala primjena ispravne doze, Lantus ulošci smiju se upotrebljavati samo sa sljedećim brizgalicama: - JuniorSTAR, kojim se lijek može dozirati u koracima od 0,5 jedinica - ClikSTAR, Tactipen, Autopen 24, AllStar ili AllStar PRO kojima se lijek može dozirati u koracima od 1 jedinice.
In the following situations, the management of your diabetes may require a lot of care (for example, adjustment to insulin dose, blood and urine tests): - If you are ill or have a major injury then your blood sugar level may increase (hyperglycaemia). 
Liječenje Vaše šećerne bolesti može zahtijevati posebnu pozornost (na primjer prilagodbu doze inzulina, pretrage krvi i urina) u sljedećim situacijama: - Ako ste bolesni ili jako ozlijeđeni, razina šećera u krvi može porasti (hiperglikemija).
Keep the cartridge at room temperature for 1 or 2 hours before inserting it in the pen. 
Uložak držite na sobnoj temperaturi 1 do 2 sata prije nego što ga umetnete u brizgalicu.
The graph above shows the activity profiles over time of insulin glargine and NPH insulin. 
Prethodni grafikon prikazuje profil djelovanja inzulina glargina i NPH inzulina kroz vrijeme.
Lantus contains insulin glargine, an insulin analogue, and has a prolonged duration of action. 
Lantus sadrži inzulin glargin, koji je inzulinski analog s produljenim djelovanjem.
Similar effects on glycohemoglobin and the incidence of symptomatic hypoglycemia were observed in both treatment groups, however fasting plasma glucose decreased more from baseline in the insulin glargine group than in the NPH group. 
Opaženi su podjednaki učinci na glikirani hemoglobin te incidenciju simptomatske hipoglikemije u obje terapijske skupine, ali razina glukoze u plazmi natašte više se smanjila u odnosu na početnu vrijednost u skupini koja je primala inzulin glargin nego u NPH skupini.
Empty pre-filled pens must never be reused and must be properly discarded. 
Prazne brizgalice nikada se ne smiju ponovno upotrebljavati i moraju se ukloniti sukladno propisima.
If administration by syringe is necessary, a vial should be used. 
Ako je potrebna primjena pomoću štrcaljke, potrebno je koristiti bočicu.
Lantus is injected under the skin. 
Način primjene Lantus se daje injekcijom pod kožu.
A. Use the injection method as instructed by your doctor, pharmacist or nurse. 
Primijenite tehniku injiciranja koju su Vam pokazali Vaš liječnik, ljekarnik ili medicinska sestra.
Metacresol 
Metakrezol
D. Keep the injection button pressed all the way in. 
Držite dugme za injiciranje pritisnutim do kraja.
These include patients: - in whom glycaemic control is markedly improved, - in whom hypoglycaemia develops gradually, - who are elderly, - after transfer from animal insulin to human insulin, 
- u kojih je regulacija glikemije izrazito poboljšana, - u kojih se hipoglikemija razvija postupno, - starije životne dobi, - koji su prešli sa životinjskog inzulina na ljudski inzulin, - u kojih je prisutna autonomna neuropatija,
In plasma, the principal circulating compound is the metabolite M1. 
Glavni cirkulirajući metabolit u plazmi je
The adverse reaction reports received from post marketing surveillance included relatively more frequent injection site reactions (injection site pain, injection site reaction) and skin reactions (rash, urticaria) in children and adolescents (≤18 years of age) than in adults. 
Prijave nuspojava nakon stavljanja lijeka u promet relativno češće uključuju reakcije na mjestu injiciranja (bol na mjestu injiciranja, reakcija na mjestu injiciranja) i kožne reakcije (osip, urtikarija) u djece i adolescenata (≤ 18 godina) nego u odraslih.
Before insertion into the pen, the cartridge must be stored at room temperature for 1 to 2 hours. 
Prije umetanja u brizgalicu, uložak se mora držati na sobnoj temperaturi 1 do 2 sata.
Do not mix Lantus with any other insulins or medicines. 
Lantus se ne smije miješati s drugim inzulinima ni drugim lijekovima.
Instead, regular insulin administered intravenously is recommended in such cases. 
U takvim se slučajevima preporučuje intravenska primjena običnog inzulina.
Lantus is a clear insulin. 
Lantus je bistar inzulin.
If your blood sugar is too high (hyperglycaemia), you may not have injected enough insulin. 
HIPERGLIKEMIJA (visoka razina šećera u krvi) Ako Vam je razina šećera u krvi previsoka (hiperglikemija), možda niste injicirali dovoljno inzulina.
Do not use Lantus 
Nemojte primjenjivati Lantus:
3 pens of 3 ml 4 pens of 3 ml 5 pens of 3 ml 6 pens of 3 ml 8 pens of 3 ml 9 pens of 3 ml 10 pens of 3 ml 
Otopina za injekciju 1 brizgalica od 3 ml 3 brizgalice od 3 ml 4 brizgalice od 3 ml 5 brizgalica od 3 ml 6 brizgalica od 3 ml 8 brizgalica od 3 ml 9 brizgalica od 3 ml 10 brizgalica od 3 ml
For information on the treatment of hyperglycaemia, see box at the end of this leaflet. 
Za informacije o liječenju hiperglikemije, pogledajte uokvireni tekst na kraju ove upute o lijeku.
If you notice signs of you blood sugar being too low (hypoglycaemia), take action to increase your blood sugar level straight away (see the box at the end of this leaflet). 
Ako primijetite znakove preniske razine šećera u krvi (hipoglikemija) odmah poduzmite mjere za povećanje razine šećera u krvi (pogledajte okvir na kraju ove upute).
Lantus in pre-filled pen is only suitable for injecting just under the skin. 
Lantus u napunjenoj brizgalici je prikladan samo za ubrizgavanje neposredno pod kožu.
In patients with hepatic impairment, insulin requirements may be diminished due to reduced capacity for gluconeogenesis and reduced insulin metabolism. 
U bolesnika s oštećenjem funkcije jetre potrebe za inzulinom mogu biti smanjene zbog smanjenog kapaciteta glukoneogeneze te usporenog metabolizma inzulina.
Only use needles that are compatible for use with SoloStar. 
Koristiti samo igle koje su prikladne za uporabu s brizgalicom SoloStar.
Switch from other insulins to Lantus 
Prijelaz s drugih inzulina na Lantus
EU/1/00/134/030 1 pen of 3 ml. 
EU/1/00/134/001 1 bočica od 5 ml
Lantus in cartridges is only suitable for injecting just under the skin using a reusable pen (see also section 3). 
Lantus u ulošcima je prikladan samo za ubrizgavanje neposredno pod kožu pomoću brizgalice za višekratnu uporabu (također vidjeti dio 3).
How to use Lantus 
Kako primjenjivati Lantus
Correspondingly, the incidences of nocturnal hypoglycaemia were 32% in the insulin glargine / lispro group versus 52% in the NPH / regular group. 
32% u skupini koja je primala inzulin glargin/lispro, naspram 52% u skupini koja je primala
Subcutaneous use Use specific pens: see leaflet. 
Koristiti odgovarajuće brizgalice: vidjeti uputu.
Lantus in pre-filled pen is only suitable for injecting just under the skin (see also section 3). 
Lantus u napunjenoj brizgalici je prikladan samo za ubrizgavanje neposredno pod kožu (također vidjeti dio 3).
You must always check the insulin label before each injection to avoid mix-ups between Lantus and other insulins. 
Prije svake injekcije morate provjeriti naljepnicu na inzulinu kako bi se izbjegla zamjena lijeka Lantus i drugih inzulina.
Rare reported side effect (may affect up to 1 in 1,000 people) 
Rijetko prijavljene nuspojave (mogu se javiti u manje od 1 na 1000 osoba)
The pharmacokinetic and pharmacodynamic findings indicate that the effect of the subcutaneous injection with Lantus is principally based on exposure to M1. Insulin glargine and the metabolite M2 were not detectable in the vast majority of subjects and, when they were detectable their concentration was independent of the administered dose of Lantus. 
Farmakokinetički i farmakodinamički nalazi pokazuju da se učinak supkutane injekcije lijeka Lantus uglavnom temelji na izloženosti metabolitu M1. U najvećeg broja ispitanika inzulin glargin i metabolit
It should be handled with care. 
Rukujte njime oprezno.
If administration by syringe is necessary, a vial should be used (see section 4.2 and 4.4). 
. Ako je potrebna primjena pomoću štrcaljke, potrebno je koristiti bočicu (vidjeti dijelove 4.2 i 4.4).
Medicines that may cause your blood sugar level to fall (hypoglycaemia) include: - all other medicines to treat diabetes, - angiotensin converting enzyme (ACE) inhibitors (used to treat certain heart conditions or high blood pressure), - disopyramide (used to treat certain heart conditions), - fluoxetine (used to treat depression), - fibrates (used to lower high levels of blood lipids), - monoamine oxidase (MAO) inhibitors (used to treat depression), - pentoxifylline, propoxyphene, salicylates (such as acetylsalicylic acid, used to relieve pain and lower fever), - sulfonamide antibiotics. 
Lijekovi koji mogu uzrokovati pad razine šećera u krvi (hipoglikemiju) obuhvaćaju: - sve druge lijekove za liječenje šećerne bolesti, - inhibitore angiotenzin konvertirajućeg enzima (ACE-inhibitore) (koriste se za liječenje nekih srčanih poremećaja ili visokog krvnog tlaka), - dizopiramid (koristi se za liječenje nekih srčanih bolesti), - fluoksetin (koristi se za liječenje depresije), - fibrate (koriste se za snižavanje visoke razine masnoća u krvi), - inhibitore monoaminooksidaze (MAO inhibitore) (koriste se za liječenje depresije),
Read carefully the "SoloStar Instructions for Use" included in this package leaflet. 
Pažljivo pročitajte „Upute za uporabu brizgalice SoloStar“ koje su sastavni dio ove upute o lijeku.
Lantus 100 units/ml solution for injection in a vial Each vial contains 5 ml of solution for injection, equivalent to 500 units, or 10 ml of solution for injection, equivalent to 1000 units. 
Lantus 100 jedinica/ml otopina za injekciju u bočici Jedna bočica sadrži 5 ml otopine za injekciju, što odgovara 500 jedinica, odnosno 10 ml otopine za injekciju, što odgovara 1000 jedinica.
Insulin label must always be checked before each injection to avoid medication errors between insulin glargine and other insulins. 
Prije svake injekcije uvijek se mora provjeriti naljepnica na inzulinu kako ne bi došlo do medikacijskih pogrešaka zbog zamjene inzulina glargina i drugih inzulina.
Lantus SoloStar 100 units/ml solution for injection in a pre-filled pen Type 1 colourless glass cartridge with a black plunger (bromobutyl rubber) and a flanged cap (aluminium) with a stopper (bromobutyl or laminate of polyisoprene and bromobutyl rubber) containing 3 ml of solution. 
Lantus SoloStar 100 jedinica/ml otopina za injekciju u napunjenoj brizgalici Uložak od bezbojnog stakla tipa 1 s crnim klipom (brombutilna guma) i zatvaračem s rubnikom (aluminij) s čepom (bromobutilna guma ili poliizoprenski laminat i bromobutilna guma) sadrži 3 ml otopine.
Solution for injection 1 cartridge of 3 ml. 
Otopina za injekciju 1 uložak od 3 ml.
The Lantus cartridges are to be used only with the pens: ClikSTAR, Tactipen, Autopen 24, AllStar, AllStar PRO, JuniorSTAR. 
Lantus ulošci smiju se koristiti samo u kombinaciji s brizgalicama: ClikSTAR, Tactipen, Autopen 24, AllStar, AllStar PRO, JuniorSTAR.
General disorders and administration site conditions Injection site reactions include redness, pain, itching, hives, swelling, or inflammation. 
Opći poremećaji i reakcije na mjestu primjene Reakcije na mjestu injiciranja uključuju crvenilo, bol, svrbež, koprivnjaču, oticanje ili upalu.
The insulin may not work very well. 
Može se dogoditi da inzulin koji injicirate na tom mjestu ne djeluje dobro.
If your blood sugar is too low (hypoglycaemia), follow the guidance for hypoglycaemia (see box at the end of this leaflet). 
Ako Vam je šećer u krvi prenizak (hipoglikemija), slijedite upute za slučaj hipoglikemije (vidjeti uokvireni tekst na kraju ove upute o lijeku).
D-65926 Frankfurt / Main Germany 
D-65926 Frankfurt na Majni
When given intravenously the elimination half-life of insulin glargine and human insulin were comparable. 
Kod intravenske primjene, poluvrijeme eliminacije inzulina glargina i ljudskog inzulina bilo je usporedivo.
The primary aim of demonstrating non-inferiority of insulin glargine to NPH in all hypoglycaemia was not met and there was a trend to an increase of hypoglycemic events with insulin glargine [insulin glargine: NPH rate ratio (95% CI) = 1.18 (0.97-1.44)]. 
Primarni cilj ispitivanja - dokazati da inzulin glargin nije inferioran u odnosu na NPH u svim slučajevima hipoglikemije - nije postignut, a zabilježen je trend povećanja broja slučajeva hipoglikemije u skupini koja je primala inzulin glargin [omjer inzulin glargin: NPH (95% CI) = 1,18 Varijabilnosti u vrijednostima glikiranog hemoglobina i glukoze bile su usporedive u obje terapijske skupine.
You may need to talk about - the availability of your insulin in the country you are visiting, 
Možda ćete morati porazgovarati o: - dostupnosti inzulina u zemlji koju posjećujete,
Opened vials, in-use cartridges or SoloStar pens For storage conditions after first opening of this medicinal product, see section 6.3. 
Uvjete čuvanja nakon prvog otvaranja lijeka, vidjeti u dijelu 6.3.
Based on your life-style and the results of your blood sugar (glucose) tests and your previous insulin usage, your doctor will - determine how much Lantus per day you will need and at what time. 
Na temelju Vašeg načina života, rezultata pretraga razine šećera (glukoze) u krvi te ranije uporabe inzulina, Vaš liječnik će:
Each ml contains 100 units insulin glargine* (equivalent to 3.64 mg). 
Jedan ml sadrži 100 jedinica inzulina glargina* (što odgovara 3,64 mg).
- If you are not eating enough your blood sugar level may become too low (hypoglycaemia). 
- Ako ne jedete dovoljno, razina šećera u krvi može postati preniska (hipoglikemija).
Step 3. 
PRILOG III.
To reduce the risk of nocturnal and early morning hypoglycaemia, patients who are changing their basal insulin regimen from a twice daily NPH insulin to a once daily regimen with Lantus should reduce their daily dose of basal insulin by 20-30% during the first weeks of treatment. 
Prijelaz s primjene NPH inzulina dvaput dnevno na Lantus Kako bi se umanjio rizik od noćne i ranojutarnje hipoglikemije, bolesnici koji prelaze s primjene bazalnog NPH inzulina dvaput na dan na Lantus jedanput na dan moraju u prvim tjednima liječenja smanjiti dozu bazalnog inzulina za 20-30%.
After subcutaneous injection of Lantus in diabetic patients, insulin glargine is rapidly metabolized at the carboxyl terminus of the Beta chain with formation of two active metabolites M1 (21A-Gly-insulin) and M2 (21A-Gly-des-30B-Thr-insulin). 
Nakon supkutane primjene lijeka Lantus u bolesnika sa šećernom bolešću inzulin glargin se brzo metabolizira na karboksilnim krajevima beta lanca, pri čemu nastaju dva aktivna metabolita: M1
You must check that your insulin pen is working properly before you inject the first dose. 
Prije injiciranja prve doze morate provjeriti radi li Vaša inzulinska brizgalica ispravno.
There were no differences between insulin glargine and standard care for the two co-primary outcomes; for any component endpoint comprising these outcomes; for all-cause mortality; or for the composite microvascular outcome. 
Nisu primijećene razlike između inzulina glargina i standardnog liječenja za dva primarna ishoda, za bilo koju mjeru koja je sastavnica navedenih ishoda,
EU/1/00/134/031 3 pens of 3 ml EU/1/00/134/032 4 pens of 3 ml EU/1/00/134/033 5 pens of 3 ml EU/1/00/134/034 6 pens of 3 ml EU/1/00/134/035 8 pens of 3 ml EU/1/00/134/036 9 pens of 3 ml EU/1/00/134/037 10 pens of 3 ml 
EU/1/00/134/030 1 brizgalica od 3 ml EU/1/00/134/031 3 brizgalice od 3 ml EU/1/00/134/032 4 brizgalice od 3 ml EU/1/00/134/033 5 brizgalica od 3 ml EU/1/00/134/034 6 brizgalica od 3 ml EU/1/00/134/035 8 brizgalica od 3 ml EU/1/00/134/036 9 brizgalica od 3 ml EU/1/00/134/037 10 brizgalica od 3 ml
EU/1/00/134/013 1 cartridge of 3 ml EU/1/00/134/014 3 cartridges of 3 ml EU/1/00/134/005 4 cartridges of 3 ml EU/1/00/134/006 5 cartridges of 3 ml EU/1/00/134/015 6 cartridges of 3 ml EU/1/00/134/016 8 cartridges of 3 ml EU/1/00/134/017 9 cartridges of 3 ml EU/1/00/134/007 10 cartridges of 3 ml 
EU/1/00/134/013 1 uložak od 3 ml EU/1/00/134/014 3 uloška od 3 ml EU/1/00/134/005 4 uloška od 3 ml EU/1/00/134/006 5 uložaka od 3 ml EU/1/00/134/015 6 uložaka od 3 ml EU/1/00/134/016 8 uložaka od 3 ml EU/1/00/134/017 9 uložaka od 3 ml EU/1/00/134/007 10 uložaka od 3 ml
Keep the pen protected from light. 
Brizgalicu čuvati zaštićenu od svjetlosti.
8 cartridges of 3 ml. 
8 uložaka od 3 ml.
Solution for injection 1 vial of 10 ml 
Otopina za injekciju 1 bočica od 10 ml
SoloStar is a pre-filled pen for the injection of insulin. 
SoloStar je napunjena brizgalica za injiciranje inzulina.
Before using the pre-filled pen, the instructions for use included in the package leaflet must be read carefully. 
Prije uporabe brizgalice SoloStar moraju se pažljivo pročitati upute za uporabu koje su sastavni dio upute o lijeku.
Examples include: - you have not injected your insulin or not injected enough, or if it has become less effective,for example through incorrect storage, - your insulin pen does not work properly, - you are doing less exercise than usual, you are under stress (emotional distress, excitement), or you have an injury, operation, infection or fever, - you are taking or have taken certain other medicines (see section 2, "Other medicines and 
Primjeri: - ako niste injicirali inzulin ili ako niste injicirali dovoljno inzulina, ili ako je djelotvornost inzulina smanjena, primjerice zbog nepravilnog čuvanja, - ako vježbate manje nego obično, ako ste pod stresom (emocionalno uznemireni ili uzbuđeni) ili ako ste ozlijeđeni ili operirani, imate infekciju ili vrućicu,
Cartridges in use (in the insulin pen) or carried as a spare may be stored for a maximum of 4 weeks not above 30°C and away from direct heat or direct light. 
Ulošci u uporabi (u inzulinskoj brizgalici) ili rezervni ulošci mogu se čuvati najdulje 4 tjedna na temperaturi do 30°C, zaštićeni od izvora topline i izravne svjetlosti.
Hypoglycaemia is also more likely to occur if - you have just begun insulin treatment or changed to another insulin preparation (when changing from your previous basal insulin to Lantus hypoglycaemia, if it occurs, may be more likely to occur in the morning than at night), - your blood sugar levels are almost normal or are unstable, - you change the area of skin where you inject insulin (for example from the thigh to the upper arm), - you suffer from severe kidney or liver disease, or some other disease such as hypothyroidism. 
Hipoglikemija se također češće može pojaviti: - ako ste upravo započeli liječenje inzulinom ili ste prešli na drugi inzulinski pripravak (kad prelazite s prethodnog bazalnog inzulina na Lantus, hipoglikemija će se, ako se javi, vjerojatnije javljati ujutro nego tijekom noći), - ako Vam je razina šećera u krvi gotovo normalna ili nije stabilna, - ako promijenite područje na koži u koje injicirate inzulin (primjerice s bedra na nadlakticu),
The cartridge in use must not be stored in a refrigerator. 
Brizgalica u uporabi ne smije se odlagati u hladnjak.
If administration by syringe is necessary, a vial should be used (see section 4.4). 
Ako je potrebna primjena pomoću štrcaljke, potrebno je koristiti bočicu (vidjeti dio 4.4).
SoloStar is a pre-filled disposable pen containing insulin glargine. 
SoloStar je napunjena brizgalica za jednokratnu uporabu koja sadrži inzulin glargin.
Lantus in cartridges is only suitable for injecting just under the skin using a reusable pen. 
Lantus u ulošcima je prikladan samo za ubrizgavanje neposredno pod kožu pomoću brizgalice za višekratnu uporabu.
In clinical studies, antibodies that cross-react with human insulin and insulin glargine were observed with the same frequency in both NPH-insulin and insulin glargine treatment groups. 
U kliničkim je ispitivanjima učestalost križnih reakcija protutijela s ljudskim inzulinom i inzulinom glarginom bila podjednaka u skupinama liječenima NPH inzulinom odnosno inzulinom glarginom.
In healthy subjects and diabetic patients, insulin serum concentrations indicated a slower and much more prolonged absorption and showed a lack of a peak after subcutaneous injection of insulin glargine in comparison to human NPH insulin. 
Nakon supkutane injekcije inzulina glargina koncentracije inzulina u serumu zdravih osoba i dijabetičara ukazivale su na sporiju i značajno dulju apsorpciju te na izostanak vršne koncentracije u usporedbi s ljudskim NPH inzulinom.
Your ability to concentrate or react may be reduced if: - you have hypoglycaemia (low blood sugar levels), - you have hyperglycaemia (high blood sugar levels), - you have problems with your sight. 
Vaša sposobnost koncentracije i reagiranja može biti oslabljena: - ako imate hipoglikemiju (nisku razinu šećera u krvi),
In use conditions: 
Brizgalice u uporabi:
The plunger will reach the end of the cartridge when the total of 300 units of insulin has been used. 
Klip će doći do kraja uloška kada se potroši svih
Injection sites must be rotated within a given injection area from one injection to the next. 
Mjesto injiciranja mora se promijeniti kod svake injekcije unutar preporučenog područja davanja.
- If you have missed a dose of Lantus or if you have not injected enough insulin, your blood sugar level may become too high (hyperglycaemia). 
Ako ste zaboravili primijeniti Lantus - Ako ste propustili dozu lijeka Lantus ili ako niste injicirali dovoljno inzulina, razina šećera u krvi može postati previsoka (hiperglikemija).
You should contact your doctor for advice on driving if: - you have frequent episodes of hypoglycaemia, - the first warning symptoms which help you to recognise hypoglycaemia are reduced or absent. 
- ako imate česte epizode hipoglikemije, - ako su Vam prvi upozoravajući znakovi hipoglikemije slabije izraženi ili izostaju.
Packs of 1, 2, 5 and 10 vials 
Pakiranja od 1, 2, 5 i 10 bočica.
LABEL (10 ml vial) 
NALJEPNICA (bočica od 10 ml)
Unopened cartridges: 
Neotvorene brizgalice:
In patients with renal impairment, insulin requirements may be diminished due to reduced insulin metabolism. 
U bolesnika s oštećenjem funkcije bubrega potrebe za inzulinom mogu biti smanjene zbog usporenog metabolizma inzulina.
A. Put the outer needle cap back on the needle, and use it to unscrew the needle from the pen. 
Vratite vanjski zatvarač igle na iglu i pomoću njega odvijte iglu s brizgalice.
Common reported side effects (may affect up to 1 in 10 people) 
Često prijavljene nuspojave (mogu se javiti u manje od 1 na 10 osoba)
It may harm them, 
ugljikohidrati),